United Therapeutics Corporation: H.C. Wainwright assumes coverage with buy rating; target price $660
UTHR•H.C. Wainwright assumed coverage of United Therapeutics Corporation with a buy rating and a $660 target price.
Related News
Monte Rosa Therapeutics plans Phase 2 gout trial of MRT-8102 in Q4 2026
GLUE•
Orthofix Medical Q3 sales of $207.9 million miss estimate of $210.5 million
OFIX•
Mizuho cuts Advance Auto Parts target price to $50 from $58
AAP•
Immunovant Q2 net income USD -97.246 million vs. IBES estimate USD -152.9 million
IMVT•
Ocular Therapeutix Q3 EPS USD -0.42
OCUL•